Looking for volunteers
Low-Intensity Extracorporeal Shockwave Therapy on Penile Rehabilitation After Robot-assisted Surgical Treatment of Genitourinary Cancers
NCT06717711 · Regina Elena Cancer Institute · Updated 14 Aug 2026
- What is being tested
- Low-intensity Extracorporeal Shock Wave Therapy (LiESWT); PDE5 inhibitor (tadalafil)
- For
- Prostate Carcinoma; Erectile Function; Genito Urinary Cancer
- Kind of study
- Tests a treatment or device on volunteers. Phase 3.
- Who can join
- Ages 18 years to 75 years. About 158 people. The full rules are on the registry page.
- Where
- Italy (2 sites)
- When
- Starts or started 15 Sept 2023, ends 28 Feb 2028. Registered 5 Dec 2024.
- Results
- None posted yet.
In the researchers' words
This prospective randomized controlled trial (RCT) is designed to provide high level evidence on the efficacy of Low-intensity Extracorporeal Shock Wave Therapy (Li-ESWT) in the treatment of post-Robot-Assisted (RA) Radical Prostatectomy (RP) erectile dysfunction (ED) in addition to PDE5 inhibitors (PDE5i) versus PDE5i alone. Our hypothesis is that early andrological rehabilitation that combines Li-ESWT and PDE5i could lead to faster and better recovery of valid erections for intercourse, with a greater rate of postoperative International Index of Erectile Function-5 (IIEF-5) compared to patients receiving PDE5i alone.
Sites
- IRCCS "Regina Elena" National Cancer InstituteRome, RM, Italy
- IRCCS "Fondazione G. Pascale" National Cancer InstituteNaples, Italy